1. Home
  2. IQV vs DTE Comparison

IQV vs DTE Comparison

Compare IQV & DTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • DTE
  • Stock Information
  • Founded
  • IQV 1982
  • DTE 1903
  • Country
  • IQV United States
  • DTE United States
  • Employees
  • IQV N/A
  • DTE N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • DTE Electric Utilities: Central
  • Sector
  • IQV Health Care
  • DTE Utilities
  • Exchange
  • IQV Nasdaq
  • DTE Nasdaq
  • Market Cap
  • IQV 31.0B
  • DTE 29.0B
  • IPO Year
  • IQV 2013
  • DTE N/A
  • Fundamental
  • Price
  • IQV $190.28
  • DTE $137.04
  • Analyst Decision
  • IQV Strong Buy
  • DTE Buy
  • Analyst Count
  • IQV 19
  • DTE 13
  • Target Price
  • IQV $229.37
  • DTE $143.33
  • AVG Volume (30 Days)
  • IQV 1.2M
  • DTE 1.1M
  • Earning Date
  • IQV 07-22-2025
  • DTE 10-23-2025
  • Dividend Yield
  • IQV N/A
  • DTE 3.19%
  • EPS Growth
  • IQV N/A
  • DTE 3.66
  • EPS
  • IQV 6.92
  • DTE 6.93
  • Revenue
  • IQV $15,700,000,000.00
  • DTE $14,201,000,000.00
  • Revenue This Year
  • IQV $6.01
  • DTE $10.21
  • Revenue Next Year
  • IQV $5.05
  • DTE $4.15
  • P/E Ratio
  • IQV $27.56
  • DTE $19.71
  • Revenue Growth
  • IQV 3.60
  • DTE 14.55
  • 52 Week Low
  • IQV $134.65
  • DTE $115.59
  • 52 Week High
  • IQV $252.88
  • DTE $142.05
  • Technical
  • Relative Strength Index (RSI)
  • IQV 56.25
  • DTE 43.34
  • Support Level
  • IQV $185.38
  • DTE $136.41
  • Resistance Level
  • IQV $193.23
  • DTE $141.51
  • Average True Range (ATR)
  • IQV 4.03
  • DTE 1.68
  • MACD
  • IQV -0.87
  • DTE -0.55
  • Stochastic Oscillator
  • IQV 56.89
  • DTE 2.75

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About DTE DTE Energy Company

DTE Energy owns two regulated utilities in Michigan that contribute 90% of earnings. DTE Electric serves approximately 2.3 million customers in southeastern Michigan, including Detroit. DTE Gas serves 1.3 million customers throughout the state. In addition, DTE has nonutility businesses and investments including energy marketing and trading, renewable natural gas facilities, and on-site industrial energy projects.

Share on Social Networks: